Ovarian cancer [NEW TOPIC PAGE]

Main|Search|PHGKB

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

---

• BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.  
  Breast cancer research : BCR 2018 Jan 20 (1): 7.
  Weber-Lassalle Nana, Hauke Jan, Ramser Juliane, Richters Lisa, Groß Eva, Blümcke Britta, Gehrig Andrea, Kahlert Anne-Karin, Müller Clemens R, Hackmann Karl, Honisch Ellen, Weber-Lassalle Konstantin, Niederacher Dieter, Borde Julika, Thiele Holger, Ernst Corinna, Altmüller Janine, Neidhardt Guido, Nürnberg Peter, Klaschik Kristina, Schroeder Christopher, Platzer Konrad, Volk Alexander E, Wang-Gohrke Shan, Just Walter, Auber Bernd, Kubisch Christian, Schmidt Gunnar, Horvath Judit, Wappenschmidt Barbara, Engel Christoph, Arnold Norbert, Dworniczak Bernd, Rhiem Kerstin, Meindl Alfons, Schmutzler Rita K, Hahnen Er
• Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.  
  Cancer genetics 2018 Jan 220 1-12.
  Apessos Angela, Agiannitopoulos Konstantinos, Pepe Georgia, Tsaousis Georgios N, Papadopoulou Eirini, Metaxa-Mariatou Vasiliki, Tsirigoti Angeliki, Efstathiadou Chrysoula, Markopoulos Christos, Xepapadakis Grigorios, Venizelos Vasileios, Tsiftsoglou Aris, Natsiopoulos Ioannis, Nasioulas Geor
• High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.  
  Breast cancer research and treatment 2018 Jan .
  Alhuqail Al-Joharah, Alzahrani Areej, Almubarak Hannah, Al-Qadheeb Sarah, Alghofaili Lamyaa, Almoghrabi Nisreen, Alhussaini Hamed, Park Ben Ho, Colak Dilek, Karakas Bed
• Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.  
  Breast cancer research and treatment 2018 Jan .
  Fan Zhenhua, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt
• No Evidence for the Pathogenicity of the BRCA2 c.6937?+?594T>G Deep Intronic Variant: A Case-Control Analysis.  
  Genetic testing and molecular biomarkers 2018 Jan .
  Dutil Julie, Godoy Lenin, Rivera-Lugo Rafael, Arroyo Nelly, Albino Elinette, Negrón Luis, Monteiro Alvaro N, Matta Jaime L, Echenique Migu

more